Schrödinger

Schrödinger is opening new worlds of possibility for drug discovery and materials design through its industry-leading computational platform which is deployed by pharmaceutical, biotechnology, chemical, and electronics companies to accelerate R&D. The Schrödinger platform revolutionizes discovery by enabling far broader exploration of chemical space and delivers better therapeutic candidates and higher-quality compounds far faster than traditional methods, at a lower cost, and with a higher probability of success. Schrödinger has built a robust pipeline of therapeutic assets, held both internally and in partnerships, and has co-founded leading biotech companies, including Nimbus Therapeutics and Morphic Therapeutic. Mission: To improve human health and quality of life by transforming the way scientists design therapeutics and materials.